buy windows 7 activation code download solidworks 2014 student edition photoshop cs6 for mac discount
  • best price autocad 2015 upgrade autocad 2011 price in india best price parallels
  • buying outlook only best buy windows xp software cheap microsoft access download much does viagra cost australia buy genuine viagra australia australian viagra online
    prescription for viagra australia viagra over the counter in sydney viagra australian model
    vendita cialis italia viagra eller cialis kamagra jelly pas cher
      diflucan comprare coumadin comprare glucophage compresse
    ou acheter viagra acheter kamagra jelly comprar viagra em portugal

    New research reveals genetic mutations of HNC

    Mon, Dec 31, 2012

    Oral Cancer News

    Author: DrBicuspid Staff

    New findings regarding the genetic mutations that cause head and neck cancer (HNC) may lead to new therapies, according to collaborative research presented in November at the 2012 Chemotherapy Foundation Symposium in New York City.

    Aaron Tward, MD, PhD, and colleagues analyzed tumor samples provided by the University of Pittsburgh from 92 patients with head and neck squamous cell carcinoma (HNSCC), according to an article on

    Patient samples were chosen to reflect the normal distribution of patients with these cancers — that is, mostly men and smokers, noted Dr. Tward. Of these patients, 89% reported a history of tobacco use and 79% alcohol use; 14% of all tumors and 53% of oropharyngeal tumors were found to be positive for human papillomavirus (HPV).

    Tumor sites also were selected to be roughly representative of the general HNSCC patient population — that is, most were oral cavity cancers, followed by a substantial proportion of oropharynx cancer samples and a few from patients with hypopharyngeal or laryngeal tumors.

    Investigators used hybrid capture sequencing to compare tumor tissue and nontumor tissue from the same patient. They also compared the total number of mutations in the HNSCC samples with samples from previous tumor studies.

    The analysis yielded a large number of mutations. For example, 5,000 genes had at least one mutation, and 1,300 had at least two, the researchers reported. Dr. Tward emphasized, however, that most of these are not implicated either in promoting or maintaining the cancer. He said the vast majority are “passengers” — that is, mutations alongside another mutation that acts as a “driver.”

    Print Friendly
    Be Sociable, Share!
    , , , , , ,

    Leave a Reply

    You must be logged in to post a comment.